Abstract
The gas-chromatographic assay for methylphenidate described here involves isolation by solid-phase extraction and quantification by thermionic nitrogen-phosphorus detection. Methylphenidate and the internal standard, ethylphenidate, are extracted from plasma by partition onto C2 reversed-phase packing. Methylphenidate and ethylphenidate are eluted, dried, derivatized with trifluoroacetic anhydride, and gas-chromatographed, with nitrogen-sensitive detection. The standard curve for the assay is linear in the range 5-100 μg/L. The within-run CV is <4%, the between-run CV <6%. Mean analytical recovery of methylphenidate was >90%. The smallest measurable concentration is 2 μg/L. The sensitivity, reproducibility, and economy of this assay make it suitable for clinical monitoring and pharmacokinetic studies.
Cite
CITATION STYLE
Potts, B. D., Martin, C. A., & Vore, M. (1984). Gas-chromatographic quantification of methylphenidate in plasma with use of solid-phase extraction and nitrogen-sensitive detection. Clinical Chemistry, 30(8), 1374–1377. https://doi.org/10.1093/clinchem/30.8.1374
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.